Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

NCT00616070 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Difluprednate
OTHER: Placebo

Sponsor

Sirion Therapeutics, Inc.